A Pilot Evaluation of the Efficacy of HistoScanning™ in Predicting the Presence and Location of Prostate Cancer in Men Undergoing Radical Prostatectomy

NYU Langone Health1 site in 1 country34 target enrollmentJune 2011

ConditionsProstate Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: NYU Langone Health
Enrollment: 34
Locations: 1
Primary Endpoint: Correlation of Histoscan findings with Radical Prostatectomy Pathology
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This pilot clinical trial studies ultrasound imaging in finding prostate cancer in patients undergoing surgery. Diagnostic procedures, such as ultrasound imaging, may help find and diagnose prostate cancer. This study will serve as an analysis of the Histo-Scanning technology for the purpose of determining its ability to identify sites of prostate cancer at the time of prostate ultrasound.

Registry

clinicaltrials.gov

Start Date

June 2011

End Date

May 2012

Last Updated

9 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Male

Investigators

Sponsor

NYU Langone Health

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients who have completed a staging multiparametric MRI at New York University (NYU)
•Patients who plan to undergo radical prostatectomy by open or robotic approach

Exclusion Criteria

•Previous History of Prostate Cancer Radiation Treatment
•Focal Ablation of the prostate for cancer treatment
•Men receiving hormonal ablation within 6 months prior to undergoing radical prostatectomy